← Open Payments lookup

MICHAEL SCOTT: Open Payments

NPI 1063058931 · MANCHESTER, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$47,000 in 145 payments from 9 companies in 2025. Trend: 2023 $343 · 2024 $468 · 2025 $47,000

Speaker / faculty: $31,001Consulting: $6,750Travel & lodging: $6,656Food & beverage: $2,593
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.59$29,857
ABBVIE INC.55$16,238
Axsome Therapeutics, Inc.15$501
Lundbeck LLC6$115
Biogen, Inc.1$100
Vanda Pharmaceuticals Inc.3$62
Otsuka America Pharmaceutical, Inc.3$59
E.R. Squibb & Sons, L.L.C.2$51
Takeda Pharmaceuticals U.S.A., Inc.1$16

Products named: INGREZZA, VRAYLAR, Auvelity, REXULTI, ZURZUVAE, FANAPT, COBENFY, TRINTELLIX.

Industry payments across NH — which companies pay providers there.